Two Sigma Advisers
XTNT icon

Two Sigma Advisers’s Xtant Medical Holdings XTNT Stock Holding History

Two Sigma Advisers’s Portfolio XTNT Stock Details XTNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,200
Closed -$11K – 2628
2020
Q3 		$11K Buy
+13,200
New +$12.9K ﹤0.01% 2369

Other funds holding XTNT

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Bruce & Co Chicago, Illinois $350M AUM 33.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Two Sigma Advisers's XTNT Position: Q4 2020 in Review

Two Sigma Advisers sold out of Xtant Medical Holdings (XTNT) in Q4 2020, closing a stake of 13,200 shares — an estimated $11K sold.

Two Sigma Advisers first reported a position in XTNT in Q3 2020 and held it in 1 quarter. The position peaked at $11K in Q3 2020. 20 funds tracked by Wall St. Rank hold XTNT as of Q4 2020.

  • Two Sigma Advisers reported no remaining Xtant Medical Holdings position as of Q4 2020 after selling out during the quarter.
  • Two Sigma Advisers sold 13,200 Xtant Medical Holdings shares in Q4 2020, an estimated $11K.
  • Two Sigma Advisers first reported a position in Xtant Medical Holdings in Q3 2020 and held it in 1 quarter.
  • Two Sigma Advisers's Xtant Medical Holdings position peaked at $11K in Q3 2020.
  • 20 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q4 2020.

Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.